Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
1/5/2024 | Equal Weight → Overweight | Barclays | |
11/17/2023 | Hold → Buy | Argus | |
5/25/2023 | $87.00 → $102.00 | Equal Weight → Overweight | Wells Fargo |
3/27/2023 | $120.00 → $95.00 | Buy → Hold | Jefferies |
12/8/2022 | $130.00 | Buy | Citigroup |
8/30/2022 | $106.00 | Sector Perform | RBC Capital Mkts |
6/7/2022 | $105.00 | Overweight → Equal Weight | Barclays |
3/24/2022 | $97.00 → $113.00 | Overweight → Equal Weight | Wells Fargo |
4 - Leidos Holdings, Inc. (0001336920) (Issuer)
4 - Leidos Holdings, Inc. (0001336920) (Issuer)
4 - Leidos Holdings, Inc. (0001336920) (Issuer)
Revenues of $4.2 billion, up 7% year-over-yearNet income of $362 million or $2.68 per diluted shareAdjusted EBITDA (non-GAAP) of $596 million (14.2% margin)Non-GAAP Diluted Earnings per Share of $2.93, up 44% year-over-yearCash Flows from Operations of $656 million; Free Cash Flow (non-GAAP) of $633 millionNet Bookings of $8.1 billion (book-to-bill ratio of 1.9 for the quarter and 1.1 for trailing twelve months)RESTON, Va., Oct. 29, 2024 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE:LDOS) today reported financial results for the third quarter of fiscal year 2024. "Continued improvement in operating performance across all segments drove excellent revenue growth, record margins for net income a
RESTON, Va., Oct. 25, 2024 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE:LDOS) announced today that its Board of Directors has declared a quarterly cash dividend of $0.40 per outstanding share of common stock of Leidos Holdings, Inc., a $0.02 increase compared to the prior quarterly dividend of $0.38 per share. The cash dividend is payable on December 31, 2024, to stockholders of record as of the close of business on December 16, 2024. About Leidos Leidos is a Fortune 500® innovation company rapidly addressing the world's most vexing challenges in national security and health. The company's global workforce of 48,000 collaborates to create smarter technology solutions for customers in heavily
RESTON, Va., Oct. 1, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS), a FORTUNE 500® innovation leader, has scheduled a conference call for Tuesday, Oct. 29, 2024, at 8 a.m. (ET) to announce its third quarter 2024 financial results for the period ending Sept. 27, 2024. The company plans to issue its quarterly earnings press release before the conference call on Oct. 29, 2024. The details for the earnings conference call follow: Date: Oct. 29, 2024 Time: 8 a.m. (ET) The company offers a live and replay audio broadcast of the conference call with corresponding press release, presentation materials, and supplemental information at http://ir.leidos.com. To listen via telephone, please follow this lin
RESTON, Va., Nov. 13, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS) today announced a $1.75 million donation to Drake State Community & Technical College in Huntsville, Alabama, creating new learning opportunities for students and allowing them to gain hands-on experience with complex technical and manufacturing projects. In recognition of this gift, Drake State will name its new advanced manufacturing facility the Leidos Advanced Training Complex. "At Leidos, we believe in the transformative power of education, and we are committed to advancing opportunities for underrepresented co
LONDON, Nov. 12, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS) has announced a partnership with the University of Edinburgh in the United Kingdom to advance AI and data science solutions. The partnership will leverage the university's Bayes Centre, an innovation hub for data science and AI, to address critical challenges in areas such as environmental, civil, healthcare, and national security. Charles Newhouse, chief technology officer for Leidos UK & Europe, said: "We are excited to partner with the University of Edinburgh, a leading centre for AI research in Europe. With its resea
RESTON, Va., Oct. 31, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS) announced today a new contract to modernize the Organ Procurement and Transplant Network (OPTN), a critical system that delivers vital organ transplant information to patients, donors, and healthcare providers. The contract was awarded by the U.S. Department of Health and Human Services through its Health Resources and Services Administration (HRSA). This multiple-award, indefinite delivery/indefinite quantity contract has a total potential value of $235 million, including a base period of performance of one-year and four one-year option periods.
4 - Leidos Holdings, Inc. (0001336920) (Issuer)
RESTON, Va., Oct. 7, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS), a Fortune 500® innovation leader, today announced the appointment of Leslie Fautsch as the company's new chief human resources officer. In this role, Fautsch will be responsible for supporting 48,000 Leidos employees worldwide and shaping the company's differentiated workforce strategy. "I am thrilled to promote Leslie as our new chief human resources officer," said Leidos CEO Tom Bell. "Leslie and our human resources team's efforts to attract and develop the best of the best people will be crucial as we make Leidos
RESTON, Va., Aug. 12, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS), a FORTUNE® 500 innovation leader, today announced the addition of Curtiss-Wright, a global provider of highly engineered, technologically advanced products and services, to the Leidos Alliance Partner Network (LAPN) as a Technology Partner. "Leidos is pleased to welcome Curtiss-Wright's Defense Solutions Division to the LAPN," said Doug Jones, Leidos' Senior Vice President of Defense Systems. "Curtiss-Wright's expertise in developing advanced, highly engineered products and precision components, combined with Leido
RESTON, Va., July 30, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS), a Fortune 500® innovation company, today announced the appointment of Ron Keesing as chief AI officer. In this role, Keesing will lead Leidos' strategic initiatives advancing Trusted Mission AI solutions and deploying those solutions across all customer missions. Leidos has been at the forefront of deploying Trusted Mission AI into critical customer missions for decades. With Keesing's appointment, Leidos is further emphasizing and accelerating efforts to deliver superior outcomes for all customer missions through
SC 13G/A - Leidos Holdings, Inc. (0001336920) (Subject)
SC 13G/A - Leidos Holdings, Inc. (0001336920) (Subject)
SC 13G/A - Leidos Holdings, Inc. (0001336920) (Subject)
144 - Leidos Holdings, Inc. (0001336920) (Subject)
10-Q - Leidos Holdings, Inc. (0001336920) (Filer)
8-K - Leidos Holdings, Inc. (0001336920) (Filer)
Barclays upgraded Leidos from Equal Weight to Overweight
Argus upgraded Leidos from Hold to Buy
Wells Fargo upgraded Leidos from Equal Weight to Overweight and set a new price target of $102.00 from $87.00 previously
- Bloomberg
Jim Lebenthal of Cerity Partners picked Cisco Systems, Inc. (NASDAQ:CSCO) on the latest edition of CNBC's “Halftime Report Final Trades.” After looking at the company’s stock chart, Lebenthal noticed there is a nine-month downtrend in the stock. The stock hit a low in June but reached a higher low a week ago. If the stock goes up 1 more percent, then we will have a “higher high,” he added. Cisco is reportedly planning to establish a cybersecurity center in Taiwan and collaborate with the local government to expand the cybersecurity workforce. The company unveiled the initiative as part of its ongoing efforts to enhance digital security infrastructure in regions facing high cyber t